Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Anthrax

Anthrax is an acute disease in humans and animals that is caused by the bacterium Bacillus anthracis and is highly lethal in some forms. Anthrax is one of only a few bacteria that can form long-lived spores. When the bacteria’s life cycle is threatened by factors such as lack of food caused by their host dying or by a change of temperature, the bacteria turn themselves into more or less dormant spores to wait for another host to continue their life cycle.On breathing, ingesting or getting spores in a cut in the skin, a new host allows these spores to reactivate themselves and multiply in their new host very rapidly. The anthrax spores in soil are very tough and can live many decades and perhaps centuries and are known to occur on all continents except Antarctica. Anthrax most commonly occurs in wild and domestic grass-eating mammals who ingest or breathe in the spores while eating grass. Anthrax can also be caught by humans when they are exposed to dead infected pigs, eat tissue from infected animals, or are exposed to a high density of anthrax spores from an animal's fur, hide, or wool. Anthrax spores can be grown outside the body and used as a biological weapon. Anthrax cannot spread directly from human to human; but anthrax spores can be transported by human clothing, shoes etc. and if a person dies of anthrax their body can be a very dangerous source of anthrax spores. The word anthrax is the Greek word for coal, the germ's name is derived from anthrakitis, the Greek word for anthracite, in reference to the black skin lesions victims develop in a cutaneous skin infection. (From the Wikpedia article Anthrax.)

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Anthrax:

Pubmed Logo
Anthrax Lethal Toxin Induced Lysosomal Membrane Permeabilization and Cytosolic Cathepsin Release Is Nlrp1b/Nalp1b-Dependent.
NOD-like receptors (NLRs) are a group of cytoplasmic molecules that...
20th November, 2009
Department of Microbiology, Immunology & Molecular Genetics, University of PLoS One. 2009 Nov 18;4(11):e7913.
DOI Direct Link
An anthrax lethal factor mutant that is defective at causing pyroptosis retains proapoptotic activity.
Anthrax lethal toxin triggers death in some cell types, such as...
20th November, 2009
Department of Laboratory Medicine and Pathobiology, University of Toronto, FEBS J. 2009 Nov 18.
DOI Direct Link
Anthrax letters: personal exposure, building contamination, and effectiveness of immediate mitigation measures.
This report is the first detailed and quantitative study of potential...
17th November, 2009
Defence R&D Canada - Suffield, Medicine Hat, Alberta, Canada. J Occup Environ Hyg. 2010 Feb;7(2):71-9.
DOI Direct Link
Detection of B. anthracis spores and vegetative cells with the same monoclonal antibodies.
Bacillus anthracis, the causative agent of anthrax disease, could be used...
17th November, 2009
State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese PLoS One. 2009 Nov 13;4(11):e7810.
DOI Direct Link
[Production and characteristics of monoclonal antibodies to the diphtheria toxin.]
Monoclonal antibodies to the diphtheria toxin were produced without cross...
17th November, 2009
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy Bioorg Khim. 2009 Sep-Oct;35(5):618-28.

View more research publications.

Press Releases About Anthrax:

BioPortfolio Logo
PharmAthene Reports Third Quarter 2009 Financial and Operational Results 12th November, 2009 PharmAthene, Inc.
-- RypVax(TM) - a recombinant dual antigen vaccine for plague For more information about PharmAthene, please visit www.PharmAthene.com. Statement on Cautionary Factors Except for the
PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security 5th October, 2009 PharmAthene, Inc.
-- Protexia® - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents For more information about
PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review 9th July, 2009 PharmAthene, Inc.
ANNAPOLIS, Md., July 9 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced
Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax 9th July, 2009 Human Genome Sciences, Inc.
ROCKVILLE, Md., July 9 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced publication by The New England Journal of Medicine of the results of two pivotal animal
Independent U.S. Study Confirms Veritide's Ceeker(TM) Handheld Device Detects Anthrax With Outstanding Accuracy and Reliability 25th June, 2009 Veritide Ltd.
--In Testing Conducted by a U.S. Research Institute, Ceeker Correctly Detected Anthrax 100% of the Time-- --Provides First Responders with a Simple and Reliable Tool to Help Quickly Distinguish

BioNews Results for Anthrax:

RSS Logo
BioPortfolio Logo
First nationwide human immunology registry for infectious disease research
News-Medical.Net:  Nov 21 2009 5:19AM Matching: anthrax
Human Immunology Registry A Research Milestone
Freshnews.com:  Nov 21 2009 12:42AM Matching: anthrax
Elsevier journal Vaccine releases a supplement dedicated to vaccines for biodefense
News-Medical.Net:  Nov 20 2009 8:12AM Matching: anthrax
Human Genome Gets FDA Response Letter for Raxibacumab Biologics License Application
TradingMarkets:  Nov 19 2009 4:36AM Matching: anthrax
HGS's Anthrax Drug Delayed by FDA
AAPS Pharmceutica:  Nov 19 2009 5:26PM Matching: anthrax
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Anthrax Clinical Trials:

Clinical Trials Logo
Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin

Anthrax Patents:

USPTO Logo
US Patent No.Title
7595193 Propagation and/or derivation of embryonic stem cells
7603894 Self-powered tire monitoring system
7604780 Ozone disinfection apparatus
7604938 Devices and methods for monitoring genomic DNA of organisms
7604978 Inhibition of biofilm formation

View more patents.

Companies working in the area of Anthrax from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

ASCIInc

ASCIInc is a premiere Healthcare and Life Science Company that understands the labyrinth of possibilities involving immunization and vaccination programs utilizes an intelligent eidetic system...
www.asciinc.com        View full profile
Thumbshot

Emergent BioSolutions

Emergent BioSolutions Inc. is a biopharmaceutical company dedicated to one simple mission—to protect life. We develop, manufacture and commercialize immunobiotics, consisting of vaccines and...
www.antexbio.com/default.aspx        View full profile
Thumbshot

Cangene Corporation

Cangene is a world leader in the development , manufacture, and commercialization of specialty hyperimmune plasma and biotechnology products. Cangene has built two decades of success with the life...
www.cangene.com/        View full profile
Thumbshot

View more Anthrax related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Anthrax scientists - we have details of around 420 individuals working on Anthrax .


This page has been viewed 545 times
Recent Search Terms used to find this page: life of anthrax virus outside the body | anthrax life cycle | life cycle of anthrax | anthrax spores pigs | anthrax life cycle | veritide patent ceeker | anthrax spores life cycle | anthrax life cycle | countermeasures against chemical threats jobs | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Anthrax across BioPortfolio, or for Anthrax Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.